| Company | Designation | Period |
|---|---|---|
| TiE-Boston | Life Sciences Volunteer and Charter Member of TiE-Boston | Jan 2003 – Jan 2011 |
| Vertex Pharmaceuticals | Research Fellow I | Jan 1996 – Jan 2008 |
| Dana Farber Cancer Institute & Harvard Medical School | Postdoc then Instructor | Jan 1989 – Jan 1996 |
| Vertex Pharmaceuticals | Research Fellow II, Disease Area Expert: Multiple Sclerosis | Apr 2008 – Nov 2011 |
| Sapien Biosciences | Co-Founder and Chief Executive Officer | Dec 2012 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Sapien Biosciences corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Jugnu Jain's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Sapien Biosciences's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)